• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Global wearable patch market growing at 10.6% rate

February 22, 2021 By Sean Whooley

G6
G6 from Dexcom

Researchers say that the global wearable patch market size is expected to reach $12.6 billion by 2026, marking a massive rise over five years.

According to the research, put together by ResearchAndMarkets.com, the rise is expected to represent a compound annual growth rate of 10.6% during the forecast period.

Wearables covered by the research, including drug delivery devices such as insulin patches and other transdermal drug delivery systems, are currently performing well on the market as a result of an increase in research & development activities for designing new products.

Growth is being boosted by continuous monitoring options and connectivity capabilities, while lifestyle diseases like diabetes will also fuel the market growth. However, governmental supports and interruptions in new product launches are hampering the market growth, according to the research.

The research cited major market moves including Abbott (NYSE:ABT) and Dexcom (NSDQ:DXCM) partnering with Insulet (NSDQ:PODD) to feed data into an automated insulin delivery system, while Abbott also paired with Sanofi (NYSE:SNY) and Dexcom entered a collaboration with Eli Lilly (NYSE:LLY).

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: abbott, Dexcom, Eli Lilly & Co., Insulet, sanofi, wearables

IN CASE YOU MISSED IT

  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS